Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
January 10 2008 - 5:05PM
PR Newswire (US)
NEW YORK, Jan. 10 /PRNewswire-FirstCall/ -- Forest Laboratories,
Inc. (NYSE:FRX), Forest Laboratories Holdings, Ltd., Merz Pharma
GmbH & Co. KgaA, and Merz Pharmaceuticals GmbH announced that
they have filed lawsuits in the U.S. District Court for the
District of Delaware against several companies for infringement of
U.S. Patent No. 5,061,703 (the '703 patent), which relates to
Forest's Namenda(R) product. The defendants named in the lawsuits
include Barr Laboratories, Inc., Cobalt Laboratories, Inc., Lupin
Ltd., Orchid Chemicals & Pharmaceuticals Ltd., Teva
Pharmaceuticals USA, Inc., Upsher-Smith Laboratories Inc.,
Wockhardt Ltd., and related companies and subsidiaries thereof. The
'703 patent expires in April 2010. Forest has applied for patent
term extension which, if granted, would extend the '703 patent
until September 2013. (Logo:
http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ) As
previously reported, Forest had received notification from several
companies that they had filed Abbreviated New Drug Applications
with Paragraph IV certifications to obtain approval to market
generic versions of Namenda. Except for the historical information
contained herein, this release contains forward-looking statements
within the meaning of the Private Securities Litigation Reform act
of 1995. These statements involve a number of risks and
uncertainties, including the difficulty of predicting FDA
approvals, the acceptance and demand for new pharmaceutical
products, the impact of competitive products and pricing, the
timely development and launch of new products, and the risk factors
listed from time to time in each of Forest Laboratories' Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, and any
subsequent SEC filings.
http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO DATASOURCE:
Forest Laboratories, Inc. CONTACT: Charles E. Triano, Vice
President, Investor Relations of Forest Laboratories, Inc.,
+1-212-224-6714, Web site: http://www.frx.com/
Copyright
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024